Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-012783
Filing Date
2022-02-07
Accepted
2022-02-07 16:09:54
Documents
2
Period of Report
2022-02-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm225605-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm225605-5_4seq1.xml 4 5839
2 EXHIBIT 24 tm225605d5_ex24.htm EX-24 8253
  Complete submission text file 0001104659-22-012783.txt   15535
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Issuer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AVEO PHARMACEUTICALS, INC. 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Ezickson Elan (Reporting) CIK: 0001486429 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36576 | Film No.: 22597460